Robb Gary Charles's Form 4 filing
Corcept Therapeutics Inc (CORT) · filed May 19, 2022
- Accession no.
- 0000899243-22-018862
- Filed
- May 19, 2022
- Trade date
- May 17-19, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $684.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Robb Gary CharlesCIK 0001529655 | Officer (Chief Business Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 17, 2022 | Common Stock | SSaleDisposed | −28,745 | $19.55 | −$561,964.75 | 42,701 | Direct | |
| May 18, 2022 | Common Stock | SSaleDisposed | −128 | $19.55 | −$2,502.4 | 42,573 | Direct | |
| May 19, 2022 | Common Stock | SSaleDisposed | −6,127 | $19.57F1 | −$119,905.39 | 36,446 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $19.55 to $19.63. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
Referenced by the price of 1 transaction in Table I.